ID	Gene Name	Species	BBID	BIOCARTA	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
1405_i_at	C-C motif chemokine ligand 5(CCL5)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,22.Cytokine-chemokine_CNS,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,	h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,	GO:0000165~MAPK cascade,GO:0002407~dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002676~regulation of chronic inflammatory response,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007159~leukocyte cell-cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0010536~positive regulation of activation of Janus kinase activity,GO:0010759~positive regulation of macrophage chemotaxis,GO:0010820~positive regulation of T cell chemotaxis,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031584~activation of phospholipase D activity,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0033634~positive regulation of cell-cell adhesion mediated by integrin,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0042102~positive regulation of T cell proliferation,GO:0042119~neutrophil activation,GO:0042327~positive regulation of phosphorylation,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0043922~negative regulation by host of viral transcription,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045089~positive regulation of innate immune response,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045785~positive regulation of cell adhesion,GO:0045948~positive regulation of translational initiation,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050796~regulation of insulin secretion,GO:0050863~regulation of T cell activation,GO:0050918~positive chemotaxis,GO:0051928~positive regulation of calcium ion transport,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070098~chemokine-mediated signaling pathway,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:0070233~negative regulation of T cell apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,GO:0090026~positive regulation of monocyte chemotaxis,GO:0098586~cellular response to virus,GO:1901214~regulation of neuron death,GO:2000406~positive regulation of T cell migration,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0016004~phospholipase activator activity,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031729~CCR4 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0042379~chemokine receptor binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,GO:0046817~chemokine receptor antagonist activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04668:TNF signaling pathway,hsa05020:Prion disease,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05142:Chagas disease,hsa05163:Human cytomegalovirus infection,hsa05164:Influenza A,hsa05168:Herpes simplex virus 1 infection,hsa05323:Rheumatoid arthritis,hsa05417:Lipid and atherosclerosis,	609423~HIV-1 disease, delayed progression of,609423~HIV-1 disease, rapid progression of,	SM00199:SCY,	KW-0145~Chemotaxis,KW-0395~Inflammatory response,	KW-0964~Secreted,	KW-0732~Signal,		KW-0202~Cytokine,	KW-0325~Glycoprotein,KW-0558~Oxidation,KW-1015~Disulfide bond,	CARBOHYD:O-linked (GalNAc...) serine; partial,DOMAIN:SCY,MUTAGEN:E->A: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:G->A,K: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:H->A: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:KKWVR->AAWVA: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:RKNR->AANA: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:T->A: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:T->A: Reduced inhibition of activity by tick evasin-4.,SITE:Cleavage; by DPP4,
1552316_a_at, 1552315_at	GTPase, IMAP family member 1(GIMAP1)	Homo sapiens				GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0005525~GTP binding,	IPR006703:AIG1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0342~GTP-binding,KW-0547~Nucleotide-binding,			DOMAIN:AIG1-type G,REGION:Disordered,REGION:G1,REGION:G2,REGION:G3,REGION:G4,REGION:G5,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical,TRANSMEM:Helical; Anchor for type IV membrane protein,
1552343_s_at	phosphodiesterase 7A(PDE7A)	Homo sapiens			GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0019933~cAMP-mediated signaling,	GO:0005829~cytosol,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0046872~metal ion binding,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa01100:Metabolic pathways,hsa05032:Morphine addiction,		SM00471:HDc,		KW-0963~Cytoplasm,	KW-0732~Signal,	KW-0114~cAMP,KW-0479~Metal-binding,	KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	ACT_SITE:Proton donor,DOMAIN:PDEase,
1552307_a_at	tetratricopeptide repeat domain 39C(TTC39C)	Homo sapiens			GO:0032474~otolith morphogenesis,GO:0060271~cilium assembly,			IPR011990:Tetratricopeptide-like helical,IPR019412:Outer membrane protein, IML2, mitochondrial/Tetratricopeptide repeat protein 39,						KW-0677~Repeat,KW-0732~Signal,KW-0802~TPR repeat,				COMPBIAS:Basic and acidic residues,REGION:Disordered,REPEAT:TPR 1,REPEAT:TPR 2,REPEAT:TPR 3,